State Street Corp G1 Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.2 - $4.98 $1.47 Million - $3.32 Million	666,850 Added 413.92%	827,956 $1.89 Million
Q2 2023 Aug 14, 2023	SELL	$2.46 - $3.14 $91,167 - $116,368	-37,060 Reduced 18.7%	161,106 $401,000
Q1 2023 May 15, 2023	BUY	$2.57 - $8.16 $47,365 - $150,388	18,430 Added 10.25%	198,166 $531,000
Q4 2022 Feb 14, 2023	SELL	$5.19 - $13.5 $7.47 Million - $19.4 Million	-1,438,645 Reduced 88.89%	179,736 $975,000
Q3 2022 Nov 15, 2022	BUY	$5.17 - $16.99 $7.63 Million - $25.1 Million	1,476,175 Added 1038.05%	1,618,381 $20.2 Million
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $14.3 Million - $30.1 Million	-3,534,608 Reduced 96.13%	142,206 $702,000
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $4.75 Million - $6.89 Million	-624,799 Reduced 14.52%	3,676,814 $27.9 Million
Q4 2021 Feb 14, 2022	SELL	$10.16 - $16.17 $833,109 - $1.33 Million	-81,999 Reduced 1.87%	4,301,613 $43.9 Million
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $21.2 Million - $36.2 Million	1,612,565 Added 58.19%	4,383,612 $58.8 Million
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $784,972 - $1.06 Million	40,111 Added 1.47%	2,771,047 $60.8 Million
Q1 2021 May 17, 2021	BUY	$17.58 - $32.59 $2.66 Million - $4.92 Million	151,117 Added 5.86%	2,730,936 $65.7 Million
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $2.36 Million - $4.38 Million	214,560 Added 9.07%	2,579,819 $46.4 Million
Q3 2020 Nov 10, 2020	BUY	$11.55 - $23.75 $11.6 Million - $23.9 Million	1,004,346 Added 73.8%	2,365,259 $27.3 Million
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $112,935 - $287,590	-11,801 Reduced 0.86%	1,360,913 $33 Million
Q1 2020 May 11, 2020	BUY	$9.07 - $26.32 $12.5 Million - $36.1 Million	1,372,714 New	1,372,714 $15.1 Million

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account